CVC raises €350m through pioneering non-recourse Evonik exchangeable
In what is thought to be the first non-recourse exchangeable bond for a private equity firm, a CVC fund raised €350m through a highly-structured bond exchangeable into shares in German chemicals firm Evonik on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: